Literature DB >> 2571116

Reflex changes induced by clonidine in spinal cord injured patients.

P W Nance1, A H Shears, D M Nance.   

Abstract

In a single blind study of 6 spinal cord injured (SCI) men, the effects of clonidine, a selective alpha-2 adrenergic agonist, on spasticity were compared to diazepam and placebo. Since a potential side-effect of clonidine is postural hypotension, a combination of clonidine and desipramine was also tested. Vibration of the leg will inhibit the H reflex in a normal subject; whereas, this inhibition is markedly reduced in SCI patients with spasticity. A vibratory inhibition index (VII) was derived for each treatment. The pre-treatment VII was 92.08 +/- 3.15%; for SCI subjects, compared to 46.5 +/- 7.7% for 6 normal subjects. Clonidine significantly reduced the mean index of SCI patients to 59.42 +/- 3.91% (p less than 0.001). The VII for placebo, diazepam and the clonidine-desipramine combination were not statistically different than the pre-treatment values in SCI patients. In conclusion, clonidine has an anti-spasticity effect in SCI patients, both subjectively, and objectively, in terms of vibratory inhibition of the H reflex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571116     DOI: 10.1038/sc.1989.44

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  6 in total

Review 1.  Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury.

Authors:  Alexander G Rabchevsky; Patrick H Kitzman
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

2.  Clonidine in the treatment of spasticity in patients with multiple sclerosis.

Authors:  O A Khan; M J Olek
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

3.  Correlation of quantitative measures with the modified Ashworth scale in the assessment of plantar flexor spasticity in patients with traumatic brain injury.

Authors:  S C Allison; L D Abraham
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

4.  Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.

Authors:  Herbert R Henney; Michael Chez
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

5.  Modulatory effects of alpha1-,alpha2-, and beta -receptor agonists on feline spinal interneurons with monosynaptic input from group I muscle afferents.

Authors:  Ingela Hammar; Elzbieta Jankowska
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

Review 6.  Drugs used to treat spasticity.

Authors:  M Kita; D E Goodkin
Journal:  Drugs       Date:  2000-03       Impact factor: 11.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.